Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Shares, $0.001 par value
-
Shares outstanding
-
15.4M
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
4.86M
-
Shares change
-
+323K
-
Total reported value, excl. options
-
$48.5M
-
Value change
-
+$3.26M
-
Number of buys
-
18
-
Number of sells
-
-21
-
Price
-
$9.99
Significant Holders of Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) as of Q1 2017
50 filings reported holding GRX - Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value as of Q1 2017.
Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.86M shares
of 15.4M outstanding shares and own 31.43% of the company stock.
Largest 10 shareholders include Karpus Management, Inc. (935K shares), MORGAN STANLEY (599K shares), First Allied Advisory Services, Inc. (596K shares), WELLS FARGO & COMPANY/MN (410K shares), RAYMOND JAMES & ASSOCIATES (356K shares), Thomas J. Herzfeld Advisors, Inc. (256K shares), GAMCO INVESTORS, INC. ET AL (233K shares), COHEN & STEERS INC (230K shares), CITIGROUP INC (191K shares), and ROYAL BANK OF CANADA (173K shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.